Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HTFB
Upturn stock ratingUpturn stock rating

Horizon Technology Finance Corporation (HTFB)

Upturn stock ratingUpturn stock rating
$24.75
Last Close (24-hour delay)
Profit since last BUY3.86%
upturn advisory
Consider higher Upturn Star rating
BUY since 136 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: HTFB (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $

1 Year Target Price $

Analysts Price Target For last 52 week
$Target price
Low$
Current$24.75
high$

Analysis of Past Performance

Type Stock
Historic Profit -0.49%
Avg. Invested days 62
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 343.84M USD
Price to earnings Ratio 20.43
1Y Target Price -
Price to earnings Ratio 20.43
1Y Target Price -
Volume (30-day avg) -
Beta 1.17
52 Weeks Range 22.70 - 25.16
Updated Date 06/29/2025
52 Weeks Range 22.70 - 25.16
Updated Date 06/29/2025
Dividends yield (FY) 5.18%
Basic EPS (TTM) 1.22

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -2.31%
Operating Margin (TTM) 84.56%

Management Effectiveness

Return on Assets (TTM) 7.25%
Return on Equity (TTM) -0.77%

Valuation

Trailing PE 20.43
Forward PE -
Enterprise Value 1200283392
Price to Sales(TTM) -
Enterprise Value 1200283392
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating -
Shares Outstanding -
Shares Floating -
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Horizon Technology Finance Corporation

stock logo

Company Overview

overview logo History and Background

Horizon Technology Finance Corporation (HRZN) was founded in 2004 and went public in 2010. It focuses on providing debt financing to venture capital-backed companies in the technology, life science, healthcare information and services, and clean-tech industries.

business area logo Core Business Areas

  • Venture Lending: Provides secured loans to venture capital-backed companies, primarily in the form of debt financing.
  • Warrants and Equity Investments: Occasionally invests in warrants or equity of portfolio companies to enhance returns.

leadership logo Leadership and Structure

Robert Pomeroy is the Chairman and Chief Executive Officer. The company operates as a business development company (BDC) with an externally managed structure.

Top Products and Market Share

overview logo Key Offerings

  • Venture Debt Financing: Provides secured loans ranging from $5 million to $30 million to companies unable to access traditional bank financing. Competitors include Ares Capital Corporation (ARCC), Golub Capital BDC (GBDC) and PennantPark Investment Corporation (PNNT). Market share information is difficult to precisely pinpoint due to the fragmented nature of the venture debt market.

Market Dynamics

industry overview logo Industry Overview

The venture debt market caters to high-growth, venture-backed companies that require capital beyond what equity financing can provide. It's a niche market impacted by the overall venture capital and technology sectors.

Positioning

HRZN positions itself as a specialized lender in the technology and life science sectors, targeting companies that are considered higher-risk but offer potential for high returns. Their competitive advantage lies in their industry expertise and relationships with venture capital firms.

Total Addressable Market (TAM)

The TAM for venture debt is estimated to be in the tens of billions of dollars annually, fluctuating with venture capital activity. HRZN has a modest market share, leaving considerable room for growth within its target segments.

Upturn SWOT Analysis

Strengths

  • Specialized industry expertise in technology and life sciences
  • Established relationships with venture capital firms
  • High dividend yield
  • Experienced management team

Weaknesses

  • High credit risk due to lending to early-stage companies
  • Reliance on external management
  • Sensitivity to economic downturns
  • Relatively small market capitalization compared to other BDCs

Opportunities

  • Expansion into new technology and life science sub-sectors
  • Increasing demand for venture debt financing
  • Strategic acquisitions of smaller lenders
  • Growing portfolio and assets under management (AUM)

Threats

  • Increased competition from other lenders
  • Rising interest rates
  • Economic recession
  • Deterioration of portfolio company performance

Competitors and Market Share

competitor logo Key Competitors

  • ARCC
  • GBDC
  • PNNT

Competitive Landscape

HRZN differentiates itself through its focus on technology and life science companies. Its smaller size can be a disadvantage compared to larger competitors like ARCC. HRZNu2019s advantage is its specialized knowledge.

Growth Trajectory and Initiatives

Historical Growth: HRZN's growth has been driven by increasing loan originations and expanding its portfolio. Historical data available from financial websites.

Future Projections: Future growth is dependent on continued demand for venture debt financing and HRZN's ability to originate high-quality loans. Analyst estimates available from financial websites.

Recent Initiatives: Recent initiatives include expanding its origination team and targeting specific technology and life science sub-sectors.

Summary

Horizon Technology Finance Corporation is a specialized lender focused on venture capital-backed tech and life science companies. The company's strengths lie in its industry expertise and high dividend yield, but it faces risks related to credit quality and economic sensitivity. Growth prospects are tied to the venture capital market's health, but the company could face increased competition. They need to monitor credit risk and manage capital efficiently.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • SEC Filings
  • Company Website
  • Financial News Outlets
  • Analyst Reports

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual risk tolerance and thorough research.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Horizon Technology Finance Corporation

Exchange NYSE
Headquaters Farmington, CT, United States
IPO Launch date 2021-04-07
Chairman & CEO Mr. Robert D. Pomeroy Jr.
Sector -
Industry -
Full time employees -
Full time employees -

Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, cleantech and sustainability industries. It seeks to invest in companies in the United States.